While alpelisib-treated and MI-503–treated tumors were smaller than vehicle-treated tumors, combined PI3K and MLL1 inhibition significantly reduced tumor volume (Fig. 5A) and endpoint tumor weight (Fig. 5B), without toxicity-associated changes to animal weight during the treatment duration (Supplementary Fig. S5A). The gene discussed is KMT2A; the disease is neoplasm.